Roundup Settlement Expected Before Christmas, Bayer CEO Says
German drugs and agrochemicals group Bayer is expecting a $7.25 billion settlement on its Roundup weedkiller to come before Christmas, CEO Bill Anderson said on Tuesday. The company is seeking to resolve tens of thousands of Roundup lawsuits through the …
German agrochemicals group Bayer is anticipating a $7.25 billion settlement on its Roundup weedkiller controversy to be reached before Christmas, CEO Bill Anderson told Reuters on Tuesday. The corporation is aiming to settle tens of thousands of Roundup lawsuits through the proposed agreement, which is being evaluated by a Missouri state court judge in St. Louis.
Anderson stated in a press call following the company’s financial results that the settlement could be finalized any time soon, with a significantly reduced number of individual cases following the agreement.
Bayer faces around 65,000 claims in US state and federal courts from plaintiffs who claim they developed non-Hodgkin lymphoma and other types of cancer after using Roundup at home or on the job. After a Supreme Court victory in June, Bayer transferred its US Roundup business to a unit called Ruveon and internally separated it from the rest of the organization. The company has maintained that decades of studies have demonstrated glyphosate, Roundup’s active ingredient, to be safe and not a cause of cancer.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
